Publication | Open Access

Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity

Chemical BiologyProteinlipid InteractionMedicinal ChemistryBiochemistryIsoform-selective Phospholipase DNatural SciencesMedicinePrivileged StructuresLipid ChemistryPharmacologyDrug DiscoveryPld1 Specificity